Recursion to Present at 43rd Annual JP Morgan Healthcare Conference

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

Recursion (NASDAQ: RXRX), a clinical stage TechBio company, has announced that its co-founder and CEO Chris Gibson, PhD, will deliver a presentation at the 43rd Annual JP Morgan Healthcare Conference in San Francisco. The presentation is scheduled for Monday, January 13, at 7:30am PT (10:30am ET) in the Elizabethan Room A/B at the Westin St. Francis.

Dr. Gibson will provide updates on three key areas: Recursion's clinical pipeline, partnerships, and platform developments following the company's recent merger with Exscientia. The presentation will be accessible on Recursion's investor relations website for a minimum of 30 days after the event.

01/06/2025 - 08:30 AM

Salt Lake City, UT, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announces that co-founder and CEO Chris Gibson, PhD will present at the upcoming 43rd Annual JP Morgan Healthcare Conference in San Francisco.

On Monday, January 13, 7:30am PT (10:30am ET), at the Westin St. Francis in the Elizabethan Room A/B, Dr. Gibson will present updates on Recursion’s latest clinical pipeline, partnerships, and platform following the company’s recent combination with Exscientia. The talk will be available on Recursion’s website for at least 30 days following the presentation here: https://ir.recursion.com/news-events/events-presentations.

FAQ

When is Recursion (RXRX) presenting at the 2025 JP Morgan Healthcare Conference?

Recursion will present on Monday, January 13, 2025, at 7:30am PT (10:30am ET) at the Westin St. Francis in San Francisco.

What topics will be covered in Recursion's (RXRX) JP Morgan Healthcare Conference presentation?

The presentation will cover updates on Recursion's clinical pipeline, partnerships, and platform developments following their combination with Exscientia.